Business Standard GLP-1 launches drive 115% rise in India's weight loss market sales in 2025
Experts say OADs, insulin to dominate anti-diabetes market, with semaglutide patent loss leading to possible price erosion, value moderation
Experts say OADs, insulin to dominate anti-diabetes market, with semaglutide patent loss leading to possible price erosion, value moderation